Trials / Terminated
TerminatedNCT05488769
Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic Material
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Thomas Nagy · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The objective is to measure the range of vision and patient reported visual disturbances after bilateral implantation for this unique non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) made from the Clareon material.
Detailed description
This study is a single-arm unmasked clinical evaluation study of binocular distance-corrected distance (6m) and intermediate (66cm) visual acuity after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at 1 day, 1 month and 3 months post-operatively. Clinical evaluations will include administration of a visual disturbance questionnaire (QUVID), and a satisfaction questionnaire (IOLSAT), as well as measurement of bilateral visual acuity and manifest refraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Clareon Vivity extended depth of focus (EDOF) intraocular lens | Implantation with the Clareon Vivity extended depth of focus (EDOF) intraocular lens |
Timeline
- Start date
- 2022-08-25
- Primary completion
- 2022-11-29
- Completion
- 2022-11-29
- First posted
- 2022-08-05
- Last updated
- 2023-01-19
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05488769. Inclusion in this directory is not an endorsement.